Press Releases
RBCC Negotiates Funding Terms With n3D
Rainbow Biosciences, the biotech division of Rainbow Coral Corp. announced today that it’s on the cusp of a major breakthrough in its business relationship with...
Press Releases
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding...
Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com) is investigating possible consumer claims against Pfizer, Inc. relating to its recent recall of certain lots of Lo/Ovral®-28...
Press Releases
Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity...
Press Releases
Alize Pharma licenses its ASPAREC(R) therapy for treatment of...
Alize Pharma II, a drug development company focused on oncology and metabolism and part of the Alize Pharma group, announced today the signing of...
Press Releases
PerkinElmer Elects Peter Barrett to Board of Directors
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that Peter Barrett, a partner...
Press Releases
Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045...
The Unilens Vision Inc.Board of Directors today declared a quarterly cash dividend of $0.045 per common share, payable February 24,2012 to stockholders of record...
Press Releases
Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.